Cargando…

Highly sensitive quantification of pemetrexed in human plasma using UPLC‐MS/MS to support microdosing studies

Pemetrexed is an antifolate drug approved for the treatment of non‐small‐cell lung cancer and mesothelioma. Assessing pemetrexed pharmacokinetics after administration of a microdose (100 μg) may facilitate drug–drug interaction and dose individualization studies with cytotoxic drugs, without causing...

Descripción completa

Detalles Bibliográficos
Autores principales: van Ewijk‐Beneken Kolmer, Eleonora W. J., Teulen, Marga J. A., Boosman, Rene J., de Rouw, Nikki, Burgers, Jacobus A., ter Heine, Rob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285051/
https://www.ncbi.nlm.nih.gov/pubmed/34741344
http://dx.doi.org/10.1002/bmc.5277
_version_ 1784747698536054784
author van Ewijk‐Beneken Kolmer, Eleonora W. J.
Teulen, Marga J. A.
Boosman, Rene J.
de Rouw, Nikki
Burgers, Jacobus A.
ter Heine, Rob
author_facet van Ewijk‐Beneken Kolmer, Eleonora W. J.
Teulen, Marga J. A.
Boosman, Rene J.
de Rouw, Nikki
Burgers, Jacobus A.
ter Heine, Rob
author_sort van Ewijk‐Beneken Kolmer, Eleonora W. J.
collection PubMed
description Pemetrexed is an antifolate drug approved for the treatment of non‐small‐cell lung cancer and mesothelioma. Assessing pemetrexed pharmacokinetics after administration of a microdose (100 μg) may facilitate drug–drug interaction and dose individualization studies with cytotoxic drugs, without causing harm to patients. Therefore, a highly sensitive bioanalytical assay is required. A reversed‐phase ultra‐high performance liquid chromatography method was developed to determine pemetrexed concentrations in human ethylenediaminetetraacetic acid–plasma after microdosing. [(13)C(5)]‐Pemetrexed was used as the internal standard. The sample preparation involved solid‐phase extraction from plasma. Detection was performed using MS/MS in a total run time of 9.5 min. The assay was validated over the concentration range of 0.0250–25.0 μg/L pemetrexed. The average accuracies for the assay in plasma were 96.5 and 96.5%, and the within‐day and between‐day precision in coefficients of variations was <8.8%. Extraction recovery was 59 ± 1 and 55 ± 5% for pemetrexed and its internal standard. Processed plasma samples were stable for 2 days in a cooled autosampler at 10°C. The assay was successfully applied in a pharmacokinetic curve, which was obtained as a part of an ongoing clinical microdosing study.
format Online
Article
Text
id pubmed-9285051
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92850512022-07-15 Highly sensitive quantification of pemetrexed in human plasma using UPLC‐MS/MS to support microdosing studies van Ewijk‐Beneken Kolmer, Eleonora W. J. Teulen, Marga J. A. Boosman, Rene J. de Rouw, Nikki Burgers, Jacobus A. ter Heine, Rob Biomed Chromatogr Research Articles Pemetrexed is an antifolate drug approved for the treatment of non‐small‐cell lung cancer and mesothelioma. Assessing pemetrexed pharmacokinetics after administration of a microdose (100 μg) may facilitate drug–drug interaction and dose individualization studies with cytotoxic drugs, without causing harm to patients. Therefore, a highly sensitive bioanalytical assay is required. A reversed‐phase ultra‐high performance liquid chromatography method was developed to determine pemetrexed concentrations in human ethylenediaminetetraacetic acid–plasma after microdosing. [(13)C(5)]‐Pemetrexed was used as the internal standard. The sample preparation involved solid‐phase extraction from plasma. Detection was performed using MS/MS in a total run time of 9.5 min. The assay was validated over the concentration range of 0.0250–25.0 μg/L pemetrexed. The average accuracies for the assay in plasma were 96.5 and 96.5%, and the within‐day and between‐day precision in coefficients of variations was <8.8%. Extraction recovery was 59 ± 1 and 55 ± 5% for pemetrexed and its internal standard. Processed plasma samples were stable for 2 days in a cooled autosampler at 10°C. The assay was successfully applied in a pharmacokinetic curve, which was obtained as a part of an ongoing clinical microdosing study. John Wiley and Sons Inc. 2021-11-22 2022-02 /pmc/articles/PMC9285051/ /pubmed/34741344 http://dx.doi.org/10.1002/bmc.5277 Text en © 2021 The Authors. Biomedical Chromatography published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
van Ewijk‐Beneken Kolmer, Eleonora W. J.
Teulen, Marga J. A.
Boosman, Rene J.
de Rouw, Nikki
Burgers, Jacobus A.
ter Heine, Rob
Highly sensitive quantification of pemetrexed in human plasma using UPLC‐MS/MS to support microdosing studies
title Highly sensitive quantification of pemetrexed in human plasma using UPLC‐MS/MS to support microdosing studies
title_full Highly sensitive quantification of pemetrexed in human plasma using UPLC‐MS/MS to support microdosing studies
title_fullStr Highly sensitive quantification of pemetrexed in human plasma using UPLC‐MS/MS to support microdosing studies
title_full_unstemmed Highly sensitive quantification of pemetrexed in human plasma using UPLC‐MS/MS to support microdosing studies
title_short Highly sensitive quantification of pemetrexed in human plasma using UPLC‐MS/MS to support microdosing studies
title_sort highly sensitive quantification of pemetrexed in human plasma using uplc‐ms/ms to support microdosing studies
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285051/
https://www.ncbi.nlm.nih.gov/pubmed/34741344
http://dx.doi.org/10.1002/bmc.5277
work_keys_str_mv AT vanewijkbenekenkolmereleonorawj highlysensitivequantificationofpemetrexedinhumanplasmausinguplcmsmstosupportmicrodosingstudies
AT teulenmargaja highlysensitivequantificationofpemetrexedinhumanplasmausinguplcmsmstosupportmicrodosingstudies
AT boosmanrenej highlysensitivequantificationofpemetrexedinhumanplasmausinguplcmsmstosupportmicrodosingstudies
AT derouwnikki highlysensitivequantificationofpemetrexedinhumanplasmausinguplcmsmstosupportmicrodosingstudies
AT burgersjacobusa highlysensitivequantificationofpemetrexedinhumanplasmausinguplcmsmstosupportmicrodosingstudies
AT terheinerob highlysensitivequantificationofpemetrexedinhumanplasmausinguplcmsmstosupportmicrodosingstudies